Page 4 - நாட்கோ பார்மா வரையறுக்கப்பட்டவை ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாட்கோ பார்மா வரையறுக்கப்பட்டவை ஆன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாட்கோ பார்மா வரையறுக்கப்பட்டவை ஆன் Today - Breaking & Trending Today

Indian pharma grows for 5th straight month; sales rise 4.5% in January

Indian pharma grows for 5th straight month; sales rise 4.5% in January
Growth in the Indian pharma market is expected to be linear ahead. The market has now grown for the fifth consecutive month and the momentum is likely to improve
Niti Kiran | February 14, 2021 | Updated 12:54 IST
The Indian pharmaceutical market s (IPM) maintained its growth trajectory for the fifth consecutive month by expanding 4.5 per cent in January. After growing 8.5 per cent in December, it grew 4.5 per cent last month, signalling that the post-Covid recovery is in full swing, pointed an Anand Rathi report.
Listed pharma companies that drove growth were Ajanta which grew 16 per cent, JB Chemicals (13.5 per cent), Ipca (12.5 per cent), Alkem (9.3 per cent) and Zydus Cadila (8.1 per cent). However, a few reported declines sales of Natco were down 38.4 per cent, Indoco (down 5.1 per cent), Alembic (down 3.6 per cent) and FDC (down 2.7 per cent). ....

Anand Rathi , Zydus Cadila , Jb Chemicals , ஆனந்த் ரதி , ஜய்துச் காடிலா , ஜ்ப் இரசாயனங்கள் ,

Natco Pharma receives registration approval for Chlorantraniliprole (CTPR)

NATCO would be the first indigenous manufacturer of this technical product.
CTPR technical is formulated into broad-spectrum insecticides used in several crops for better pest
management. NATCO hopes to bri ng products based on CTPR shortly that would be affordable and
accessible to farmers across India.
CTPR is an active ingredient used in products commercialized by FMC under brands Coragen &
Ferterra.
Th e sales generated from CTPR containing products in India, inclusive of third-party
marketing companies, as per declaration given by FMC was estimated to be Rs 1540 crores in 2016. NATCO believes the current market size to be over Rs 2000 crore. NATCO has a pending litigation ....

Coragen Ferterra , Natco Pharma , Registration Committee , Central Insecticide Board , Insecticides Act , Capital Market , Northern Areas Transport Corporation , Chemical Substances , Cng Products , Indigenous Manufacturer , நாட்கோ பார்மா , பதிவு குழு , மைய பூச்சிக்கொல்லி பலகை , பூச்சிக்கொல்லிகள் நாடகம் , மூலதனம் சந்தை , வடக்கு பகுதிகள் போக்குவரத்து நிறுவனம் , ங் ப்ராடக்ட்ஸ் , உள்நாட்டு உற்பத்தியாளர் ,

Natco Pharma gains after regulatory approval for CTPR

Natco Pharma rose 2.30% to Rs 920.45 after the company said it received approval for chlorantraniliprole (CTPR)-1st key product of crop health sciences division.
In a BSE filing made during market hours today, the company announced the approval of registration by the Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of chlorantraniliprole (CTPR) Technical.
NATCO would be the 1st indigenous manufacturer of this technical product, the company said in the filing.
CTPR technical is formulated into broad-spectrum insecticides used in several crops for better pest management. The active ingredient is used across products commercialised by FMC under its brands Coragen and Ferterra. ....

Andhra Pradesh , Natco Pharma , Central Insecticide Board Registration Committee , Central Insecticide Board , Registration Committee , Capital Market , Northern Areas Transport Corporation , Indigenous Manufacturer , ஆந்திரா பிரதேஷ் , நாட்கோ பார்மா , மைய பூச்சிக்கொல்லி பலகை பதிவு குழு , மைய பூச்சிக்கொல்லி பலகை , பதிவு குழு , மூலதனம் சந்தை , வடக்கு பகுதிகள் போக்குவரத்து நிறுவனம் , உள்நாட்டு உற்பத்தியாளர் ,

Natco Pharma's comparatively reasonable valuation makes it stock pick of the week

Natco Pharma s comparatively reasonable valuation makes it stock pick of the week
With the fear of the pandemic going away, sales from other divisions are expected to normalise soon.
Synopsis
Natco’s recent diversification of its exports to markets like Brazil, Canada, China, is doing well and is expected to do so in future as well. Besides, its valuations despite the recent jump are not high compared to other pharma companies.
Natco Pharma has surprised the market with yo-y revenue and net profit growth of 65% and 70% respectively in the second quarter of 2020-21. Pandemic related demand jump in its key product Tamiflu and Revlimid settlement have boosted the second quarter numbers. This ‘above average growth’ should not be taken as the norm. However, analysts believe that this research and development focused mid-size pharma company will repeat good performance in ....

Natco Pharma , Stock Market , Natco Pharma Share Price , Natco Pharma Ltd , Covid 19 , நாட்கோ பார்மா , ஸ்டாக் சந்தை , சர்வதேச பரவல் , நாட்கோ பார்மா பகிர் ப்ரைஸ் , நாட்கோ பார்மா லிமிடெட் ,

Natco Pharma share price: Reasonable valuations makes this midcap pharma stock an attractive buy

Reasonable valuations makes this midcap pharma stock an attractive buy
With the fear of the pandemic going away, sales from other divisions are expected to normalise soon.
Synopsis
Natco’s recent diversification of its exports to markets like Brazil, Canada, China, is doing well and is expected to do so in future as well. Besides, its valuations despite the recent jump are not high compared to other pharma companies. This has made the company a favourite of analysts.
Natco Pharma has surprised the market with yo-y revenue and net profit growth of 65% and 70% respectively in the second quarter of 2020-21. Pandemic related demand jump in its key product Tamiflu and Revlimid settlement have boosted the second quarter numbers. This ‘above average growth’ should not be taken as the norm. However, analysts believe that this research and development focused mid-size pharma company will repeat good performance in ....

Natco Pharma , Stock Market , Natco Pharma Share Price , Natco Pharma Ltd , Covid 19 , நாட்கோ பார்மா , ஸ்டாக் சந்தை , சர்வதேச பரவல் , நாட்கோ பார்மா பகிர் ப்ரைஸ் , நாட்கோ பார்மா லிமிடெட் ,